Cravath, Swaine & Moore LLP Logo
  • Practices
  • People
  • Careers
  • News & Insights
  • Practices
  • People
  • Careers
  • News & Insights
  • Our Story
  • The Cravath System
  • Diversity & Inclusion
  • Pro Bono
  • Alumni Journal
  • 200.Cravath

Cravath’s London Office Moves to 100 Cheapside

Read More

News & Insights

TG Therapeutics, Inc.’s Registered Primary Common Stock Offering

December 31, 2020

Cravath represented the underwriters, led by J.P. Morgan Securities, Goldman Sachs & Co. LLC, Evercore ISI and Cantor, in connection with the $316 million registered primary common stock offering of TG Therapeutics, Inc., a biopharmaceutical company dedicated to developing and delivering medicines for patients with B‑cell mediated diseases. The transaction closed on December 17, 2020.

The Cravath team included partners William V. Fogg and Michael E. Mariani and associates Melanie R. Cook and Parth S. Baxi on capital markets matters, and associate Duncan H. Hardell on tax matters. Ahra Cho also worked on capital markets matters and Joana W. Li also worked on tax matters.

Related Practices & Industries

  • Corporate
  • Capital Markets
  • Tax
  • Healthcare and Life Sciences

People

Photo
Name
William V. Fogg
Title
Corporate
Title
Partner
Email
wfogg@cravath.com
Phone
+1-212-474-1131
vCard
Download vCard

    Education

    • J.D., 1991, Columbia Law School
      Harlan Fiske Stone Scholar
    • A.B., 1988, Brown University
      magna cum laude

    Admitted In

    • New York
    Photo
    Name
    Michael E. Mariani
    Title
    Corporate
    Title
    Partner
    Email
    mmariani@cravath.com
    Phone
    +1-212-474-1007
    vCard
    Download vCard

      Education

      • J.D., 2009, Columbia Law School
        Harlan Fiske Stone Scholar
      • M.B.A., 2009, Columbia University
      • B.A., 2004, Tufts University
        Phi Beta Kappa, summa cum laude

      Admitted In

      • New York

      Related News & Insights

      Deals & Cases

      November 18, 2025

      Ripple Labs, Inc.’s Private Placement of Class A Common Stock

      Cravath represented funds managed by affiliates of Brevan Howard in connection with an investment in Ripple Labs, Inc., consisting of a private placement of Class A Common Stock, as part of Ripple’s $500 million strategic investment at a $40 billion valuation, led by funds managed by affiliates of Fortress Investment Group, affiliates of Citadel Securities, Pantera Capital, Galaxy Digital, Brevan Howard and Marshall Wace. The transaction closed on November 4, 2025.

      Deals & Cases

      October 31, 2025

      Danaos Corporation’s High‑Yield Senior Notes Offering

      Cravath represented the initial purchasers in connection with the $500 million 144A/Reg. S high‑yield senior notes offering of Danaos Corporation, a global shipping company that operates one of the world's largest fleets of containerships. The transaction closed on October 17, 2025.

      Deals & Cases

      October 27, 2025

      Cleveland‑Cliffs Inc.’s High‑Yield Senior Guaranteed Notes Offering

      Cravath represented the initial purchaser in connection with the $275 million 144A/Reg. S high‑yield senior guaranteed notes offering of Cleveland‑Cliffs Inc., a leading North America‑based steel producer. The transaction closed on October 10, 2025.

      Deals & Cases

      October 15, 2025

      Royal Caribbean Cruises Ltd.’s $1.5 Billion Registered Senior Notes Offering

      Cravath represented the underwriters in connection with the $1.5 billion registered senior notes offering of Royal Caribbean Cruises Ltd., a global cruise company. The transaction closed on October 1, 2025.

      Cravath Bicentennial

      Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

      Explore

      Cravath, Swaine & Moore LLP Logo
      • CONTACT US
      • OUR STORY
      • ALUMNI PORTAL
      • DISCLAIMERS & NOTICES

      Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.